PL2167526T3 - Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej - Google Patents

Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej

Info

Publication number
PL2167526T3
PL2167526T3 PL08786090T PL08786090T PL2167526T3 PL 2167526 T3 PL2167526 T3 PL 2167526T3 PL 08786090 T PL08786090 T PL 08786090T PL 08786090 T PL08786090 T PL 08786090T PL 2167526 T3 PL2167526 T3 PL 2167526T3
Authority
PL
Poland
Prior art keywords
purification
factor viii
mixed
mode
multimodal resin
Prior art date
Application number
PL08786090T
Other languages
English (en)
Inventor
Susanne Bang
Lars Thim
Johan Karlsson
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL2167526T3 publication Critical patent/PL2167526T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL08786090T 2007-07-11 2008-07-11 Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej PL2167526T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07112287 2007-07-11
PCT/EP2008/059094 WO2009007451A1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin
EP08786090A EP2167526B1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin

Publications (1)

Publication Number Publication Date
PL2167526T3 true PL2167526T3 (pl) 2011-09-30

Family

ID=38472947

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08786090T PL2167526T3 (pl) 2007-07-11 2008-07-11 Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej

Country Status (15)

Country Link
US (1) US8399620B2 (pl)
EP (1) EP2167526B1 (pl)
JP (1) JP5323072B2 (pl)
KR (1) KR101293504B1 (pl)
CN (1) CN101730707B (pl)
AT (1) ATE503763T1 (pl)
AU (1) AU2008274195B2 (pl)
BR (1) BRPI0814220B8 (pl)
CA (1) CA2692814A1 (pl)
DE (1) DE602008005885D1 (pl)
ES (1) ES2364118T3 (pl)
NL (1) NL300663I2 (pl)
PL (1) PL2167526T3 (pl)
RU (1) RU2493163C2 (pl)
WO (1) WO2009007451A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329871B2 (en) * 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII
WO2010020690A1 (en) 2008-08-21 2010-02-25 Octapharma Ag Recombinantly produced human factor viii and ix
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US8277649B2 (en) 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
CA2790786C (en) * 2010-02-24 2019-09-24 Zymenex A/S Process for production and purification of recombinant lysosomal alpha-mannosidase
EP2552948B1 (en) 2010-03-30 2016-07-13 Octapharma AG Process for the purification of growth factor protein g-csf
CN102858971B (zh) 2010-03-30 2016-06-01 奥克塔法马股份有限公司 纯化维生素k依赖性蛋白如凝血因子ix的方法
WO2012059495A1 (en) * 2010-11-05 2012-05-10 F. Hoffmann-La Roche Ag Optimized method for antibody capturing by mixed mode chromatography
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
MX379269B (es) 2012-10-24 2025-03-11 Genzyme Corp Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil.
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN103396494B (zh) * 2013-04-27 2015-04-01 江苏省疾病预防控制中心 一种凝血因子ix的单克隆抗体
DK2994485T3 (en) 2013-05-06 2018-04-23 Sanofi Sa CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES
CA2951408A1 (en) * 2014-06-25 2015-12-30 Jhl Biotech, Inc. Methods and reagents for purification of proteins
JP6516829B2 (ja) 2014-08-04 2019-05-22 シーエスエル、リミテッド 第viii因子製剤
SG11201706659WA (en) 2015-03-06 2017-09-28 Csl Behring Recombinant Facility Ag Modified von willebrand factor having improved half-life
GB201506113D0 (en) * 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
GB201506117D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
EP3205665A1 (en) * 2016-02-11 2017-08-16 Octapharma AG Method of separating factor viii from blood products
GB201617240D0 (en) * 2016-10-11 2016-11-23 Profactor Pharma Ltd Purification process
EP3642225A1 (en) 2017-06-23 2020-04-29 Baxalta Incorporated Purification of factor viii subspecies
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
WO2021001522A1 (en) 2019-07-04 2021-01-07 CSL Behring Lengnau AG A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii
WO2021094344A1 (en) 2019-11-11 2021-05-20 CSL Behring Lengnau AG Polypeptides for inducing tolerance to factor viii

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302006D0 (sv) * 1992-10-02 1993-06-11 Kabi Pharmacia Ab Protein formulation
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
IL157309A0 (en) 2003-08-07 2004-02-19 Applied Research Systems Method for the purification of a non-immunoglobulin protein
EP1831242B1 (en) 2004-12-23 2012-09-26 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
US8329871B2 (en) 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII

Also Published As

Publication number Publication date
KR20100051620A (ko) 2010-05-17
BRPI0814220B8 (pt) 2021-05-25
NL300663I2 (pl) 2016-09-22
RU2010103528A (ru) 2011-08-20
EP2167526A1 (en) 2010-03-31
AU2008274195B2 (en) 2013-09-05
US20100204452A1 (en) 2010-08-12
BRPI0814220B1 (pt) 2019-09-17
US8399620B2 (en) 2013-03-19
RU2493163C2 (ru) 2013-09-20
KR101293504B1 (ko) 2013-08-07
CA2692814A1 (en) 2009-01-15
ES2364118T9 (es) 2014-05-19
JP2010533150A (ja) 2010-10-21
JP5323072B2 (ja) 2013-10-23
BRPI0814220A2 (pt) 2015-01-06
EP2167526B1 (en) 2011-03-30
CN101730707B (zh) 2014-12-17
ATE503763T1 (de) 2011-04-15
WO2009007451A1 (en) 2009-01-15
DE602008005885D1 (de) 2011-05-12
CN101730707A (zh) 2010-06-09
AU2008274195A1 (en) 2009-01-15
ES2364118T3 (es) 2011-08-25

Similar Documents

Publication Publication Date Title
NL300663I2 (pl)
NZ781143A (en) Anti-vegf protein compositions and methods for producing the same
WO2005103083A8 (en) Anti-cd38 human antibodies and uses therefor
AU2016222301A1 (en) Isolation and purification of antibodies using Protein A affinity chromatography
MX2010002769A (es) Preparacion recombinante de fracciones de bromelaina seleccionadas.
MX2012004711A (es) Aislamiento y purificacion de los anticuerpos anti-il-13 al usar cromatografia de afinidad con proteina a.
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
WO2009068625A3 (en) Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
GEP20135917B (en) Stabilized polypeptide compositions
EA200970403A1 (ru) Бициклические триазолы в качестве модуляторов протеинкиназы
MY162624A (en) Antibodies directed to her-3 and uses thereof
SI2174946T1 (sl) Metode za kemično sintetiziranje himernih proteinov imunoglobulina
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
MX2015008875A (es) Metodos para la purificacion de arilsulfatasa a.
IL199753A0 (en) Process for the purification of fc-containing proteins
WO2004002418A3 (en) Compositions and methods comprising protein activated receptor antagonists
ZA202110285B (en) Antibodies and methods of use
WO2006117782A3 (en) Recombinant antibodies against cd55 and cd59 and uses thereof
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
WO2008051178A3 (en) Purification of proteins with cationic surfactant
TW200715985A (en) Systems and methods for separating proteins from connective tissue
WO2010040736A3 (en) Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling
WO2010011994A3 (en) Polypeptides and uses thereof
EP4118093A4 (en) METHOD FOR PURIFYING A FC FUSION PROTEIN